CIK: 0001731118
Total reported value
$1.7B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | FTI | TechnipFMC plc | Stock-Energy | 45.29% | — | — | |
| 2 | CSTM | Constellium SE | Stock-Other | 36.91% | — | — | |
| 3 | CRTO | Criteo Sa-spon Adr | Stock-Other | 9.50% | — | — | |
| 4 | ✓ | Stock-Other | 5.78% | — | -2.07% | ||
| 5 | ✓ | Cellectis S A | Stock-Other | 2.26% | — | — | |
| 6 | ✓ | Millendo Therapeutics INC | Stock-Other | 0.25% | — | -50.23% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CSTM | Constellium SE | +5.9% | — | Unchanged |
| 2 | FTI | TechnipFMC plc | +3.5% | — | Unchanged |
| 3 | CRTO | Criteo Sa-spon Adr | +1.9% | — | Unchanged |
| 4 | ✓ | +0.6% | -2.07% | Trim | |
| 5 | ✓ | Millendo Therapeutics INC | -0.2% | -50.23% | Trim |
| 6 | TLND | Talend SA - Adr | — | EXIT | Sold out |
| 7 | ✓ | Cellectis S A | — | NEW | New buy |
| 8 | CRNX | Crinetics Pharmaceuticals In | — | EXIT | Sold out |